Beligas Pharma Quant EQ-500 (Boldenone Undecylenate) Beligas

£132.00

Beligas Pharma Quant EQ-500 provides boldenone undecylenate for advanced steroid research applications. Pharmaceutical-grade formulation designed for laboratory investigations and in-vitro molecular studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Beligas Pharma Quant EQ-500 (Boldenone Undecylenate) Beligas
Beligas Pharma Quant EQ-500 (Boldenone Undecylenate) Beligas
£132.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Beligas Pharma Quant EQ-500 (Boldenone Undecylenate) Beligas at a Glance

Beligas Pharma Quant EQ-500 is a synthetic anabolic steroid derivative containing boldenone undecylenate as the active pharmaceutical compound. This research chemical represents a long-acting esterified form of boldenone, originally developed for veterinary applications but now extensively studied in laboratory settings. Researchers at Stroid UK Shop utilise this compound to examine androgenic receptor binding patterns, protein synthesis modulation, and nitrogen retention mechanisms in controlled experimental environments.

The undecylenate ester provides extended pharmacokinetic properties compared to shorter-acting variants, making it valuable for longitudinal research protocols. Scientists investigate its molecular interactions with androgen receptors, particularly examining tissue-selective anabolic effects versus androgenic activity ratios. This compound serves as an important reference standard in comparative studies with other anabolic agents found in our boldenone research collection.

Laboratory Research Applications

Research teams employ Beligas Pharma Quant EQ-500 to examine cellular uptake mechanisms, metabolic pathway interactions, and receptor binding kinetics in tissue culture systems. The 500mg/ml concentration provides researchers with consistent dosing accuracy for experimental protocols requiring precise molecular ratios. Studies focus on understanding how boldenone undecylenate modulates gene expression patterns related to muscle protein synthesis and cellular growth factors.

Comparative analyses with compounds from our SARMS category and peptide research section help researchers understand different molecular pathways involved in anabolic signalling. Laboratory investigations examine the compound’s interaction with cytochrome P450 enzymes, aromatase activity, and potential conversion to secondary metabolites under controlled conditions.

Product Specifications

Beligas Pharma Quant EQ-500 Technical Data
Parameter Specification
Active Ingredient Boldenone Undecylenate
Concentration 500mg/ml
Pharmaceutical Grade Research Standard
CAS Number Verify with supplier
Molecular Weight Verify with supplier
Storage Requirements Cool, dry conditions
Purity Pharmaceutical grade

Research Compliance Statement

Beligas Pharma Quant EQ-500 is manufactured exclusively for in-vitro research purposes and laboratory analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Research institutions must ensure proper handling protocols, safety equipment, and disposal procedures when working with this compound. All studies should comply with institutional review board guidelines and local regulations governing research chemical usage in laboratory settings.

Related